Is there a place for Ramucirumab after Sorafenib in patients with advanced HCC?

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common incident and the fourth most common cause of cancer death worldwide. It is strongly associated with chronic Hepatitis B and C infection and excess alcohol intake (1), making treatment of patients with HCC complicated, with the almost uniform presence of concurrent cirrhosis and varying degrees of liver failure, which often fluctuates over time.
Original languageEnglish
Number of pages3
JournalHepatobiliary Surgery and Nutrition
DOIs
Publication statusAccepted/In press - Apr 2019

Cite this

@article{6d5dcb6304354f35970f07d36d8cb23f,
title = "Is there a place for Ramucirumab after Sorafenib in patients with advanced HCC?",
abstract = "Hepatocellular carcinoma (HCC) is the sixth most common incident and the fourth most common cause of cancer death worldwide. It is strongly associated with chronic Hepatitis B and C infection and excess alcohol intake (1), making treatment of patients with HCC complicated, with the almost uniform presence of concurrent cirrhosis and varying degrees of liver failure, which often fluctuates over time.",
author = "So, {Yeo Jeong} and Sophia Frentzas and Eva Segelov",
year = "2019",
month = "4",
doi = "10.21037/hbsn.2019.04.14",
language = "English",
journal = "Hepatobiliary Surgery and Nutrition",
issn = "2304-3881",
publisher = "AME Publishing Company",

}

Is there a place for Ramucirumab after Sorafenib in patients with advanced HCC? / So, Yeo Jeong ; Frentzas, Sophia; Segelov, Eva.

In: Hepatobiliary Surgery and Nutrition, 04.2019.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

TY - JOUR

T1 - Is there a place for Ramucirumab after Sorafenib in patients with advanced HCC?

AU - So, Yeo Jeong

AU - Frentzas, Sophia

AU - Segelov, Eva

PY - 2019/4

Y1 - 2019/4

N2 - Hepatocellular carcinoma (HCC) is the sixth most common incident and the fourth most common cause of cancer death worldwide. It is strongly associated with chronic Hepatitis B and C infection and excess alcohol intake (1), making treatment of patients with HCC complicated, with the almost uniform presence of concurrent cirrhosis and varying degrees of liver failure, which often fluctuates over time.

AB - Hepatocellular carcinoma (HCC) is the sixth most common incident and the fourth most common cause of cancer death worldwide. It is strongly associated with chronic Hepatitis B and C infection and excess alcohol intake (1), making treatment of patients with HCC complicated, with the almost uniform presence of concurrent cirrhosis and varying degrees of liver failure, which often fluctuates over time.

U2 - 10.21037/hbsn.2019.04.14

DO - 10.21037/hbsn.2019.04.14

M3 - Meeting Abstract

JO - Hepatobiliary Surgery and Nutrition

JF - Hepatobiliary Surgery and Nutrition

SN - 2304-3881

ER -